Paul Morelli, P.A.-C

NPI: 1821008970
Total Payments
$1,966
2024 Payments
$395.47
Companies
19
Transactions
86
Medicare Patients
2,804
Medicare Billing
$119,137

Payment Breakdown by Category

Food & Beverage$1,536 (78.1%)
Education$430.03 (21.9%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,536 81 78.1%
Education $430.03 5 21.9%

Top Paying Companies

Company Total Records Latest Year
Astellas Pharma US Inc $722.23 25 $0 (2024)
UROVANT SCIENCES INC $255.99 11 $0 (2022)
Antares Pharma, Inc. $184.75 8 $0 (2024)
Sumitomo Pharma America, Inc. $141.17 9 $0 (2023)
Myovant Sciences Inc. $108.54 6 $0 (2022)
PFIZER INC. $77.36 5 $0 (2024)
ABBVIE INC. $63.67 3 $0 (2024)
Bayer Healthcare Pharmaceuticals Inc. $60.07 3 $0 (2024)
Axonics, Inc. $58.74 3 $0 (2023)
COLOPLAST CORP $43.71 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $395.47 17 Antares Pharma, Inc. ($184.75)
2023 $376.19 22 Sumitomo Pharma America, Inc. ($141.17)
2022 $851.57 33 Astellas Pharma US Inc ($377.28)
2021 $342.88 14 Astellas Pharma US Inc ($239.64)

All Payment Transactions

86 individual payment records from CMS Open Payments — Page 1 of 4

Date Company Product Nature Form Amount Type
12/13/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $11.18 General
Category: TESTOSTERONE REPLACEMENT THERAPY
11/12/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $109.37 General
Category: TESTOSTERONE REPLACEMENT THERAPY
10/21/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $10.43 General
Category: TESTOSTERONE REPLACEMENT THERAPY
10/16/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $19.72 General
Category: UROLOGY
09/30/2024 Dendreon Pharmaceuticals LLC PROVENGE (Drug) Food and Beverage In-kind items and services $33.64 General
Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER
09/25/2024 Ambu Inc. Food and Beverage Cash or cash equivalent $34.70 General
09/23/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $13.04 General
Category: TESTOSTERONE REPLACEMENT THERAPY
08/28/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $20.79 General
Category: UROLOGY
08/21/2024 PFIZER INC. XTANDI (Drug), ORGOVYX, TALZENNA Food and Beverage In-kind items and services $15.05 General
Category: ONCOLOGY
08/19/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $10.43 General
Category: TESTOSTERONE REPLACEMENT THERAPY
08/13/2024 ABBVIE INC. LUPRON DEPOT (Drug) Food and Beverage In-kind items and services $22.60 General
Category: ENDOCRINOLOGY
07/24/2024 COLOPLAST CORP Titan (Device) Food and Beverage In-kind items and services $26.56 General
Category: Men's Health
06/17/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $10.43 General
Category: TESTOSTERONE REPLACEMENT THERAPY
06/06/2024 Bayer Healthcare Pharmaceuticals Inc. Nubeqa (Drug) Food and Beverage In-kind items and services $20.42 General
Category: Oncology
04/22/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $8.69 General
Category: TESTOSTERONE REPLACEMENT THERAPY
04/01/2024 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $17.24 General
Category: Oncology
03/11/2024 Antares Pharma, Inc. XYOSTED (Drug) Food and Beverage In-kind items and services $11.18 General
Category: TESTOSTERONE REPLACEMENT THERAPY
12/11/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $13.64 General
Category: Urology
11/06/2023 Astellas Pharma US Inc Myrbetriq (Drug) Food and Beverage In-kind items and services $16.29 General
Category: Urology
10/18/2023 Astellas Pharma US Inc Xtandi (Drug) Food and Beverage In-kind items and services $18.69 General
Category: Oncology
10/11/2023 PFIZER INC. XTANDI (Drug), ORGOVYX, COMIRNATY Food and Beverage In-kind items and services $14.73 General
Category: ONCOLOGY
09/14/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $12.93 General
Category: HORMONE THERAPY
08/30/2023 PFIZER INC. XTANDI (Drug), ORGOVYX Food and Beverage In-kind items and services $14.41 General
Category: ONCOLOGY
08/22/2023 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $13.64 General
Category: Urology
08/09/2023 Sumitomo Pharma America, Inc. ORGOVYX (Drug) Food and Beverage In-kind items and services $19.83 General
Category: HORMONE THERAPY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 735 10,280 $131,757 $36,041
2022 9 888 7,726 $144,650 $39,354
2021 11 579 645 $81,011 $22,803
2020 8 602 7,627 $92,509 $20,939
Total Patients
2,804
Total Services
26,278
Medicare Billing
$119,137
Procedure Codes
39

All Medicare Procedures & Services

39 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 236 360 $57,600 $18,293 31.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 34 34 $12,410 $3,369 27.2%
74178 Ct scan of abdomen and pelvis before and after contrast Office 2023 16 17 $12,705 $3,225 25.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 45 49 $11,662 $3,141 26.9%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 44 44 $10,516 $2,897 27.6%
74176 Ct scan of abdomen and pelvis without contrast Office 2023 17 21 $6,681 $1,674 25.1%
51798 Ultrasound measurement of bladder capacity after voiding Office 2023 160 208 $11,648 $1,435 12.3%
36415 Insertion of needle into vein for collection of blood sample Office 2023 119 155 $3,100 $1,302 42.0%
96372 Injection of drug or substance under skin or into muscle Office 2023 12 43 $1,763 $357.29 20.3%
J1071 Injection, testosterone cypionate, 1 mg Office 2023 11 9,305 $2,792 $197.29 7.1%
81002 Urinalysis, manual test Office 2023 41 44 $880.00 $150.04 17.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 187 238 $38,080 $12,756 33.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 113 113 $41,245 $11,009 26.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 107 125 $29,750 $9,051 30.4%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 62 62 $14,818 $3,699 25.0%
51798 Ultrasound measurement of bladder capacity after voiding Office 2022 159 214 $11,984 $1,557 13.0%
36415 Insertion of needle into vein for collection of blood sample Office 2022 151 178 $3,560 $527.46 14.8%
81002 Urinalysis, manual test Office 2022 81 95 $1,900 $323.27 17.0%
96372 Injection of drug or substance under skin or into muscle Office 2022 14 32 $1,312 $291.08 22.2%
J1071 Injection, testosterone cypionate, 1 mg Office 2022 14 6,669 $2,001 $141.13 7.1%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 95 107 $25,466 $8,415 33.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 120 138 $22,080 $7,461 33.8%
74176 Ct scan of abdomen and pelvis Office 2021 13 15 $8,745 $1,706 19.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 16 16 $5,840 $1,652 28.3%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 15 15 $3,585 $1,114 31.1%

About Paul Morelli, P.A.-C

Paul Morelli, P.A.-C is a Medical healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821008970.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Paul Morelli, P.A.-C has received a total of $1,966 in payments from pharmaceutical and medical device companies, with $395.47 received in 2024. These payments were reported across 86 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,536).

As a Medicare-enrolled provider, Morelli has provided services to 2,804 Medicare beneficiaries, totaling 26,278 services with total Medicare billing of $119,137. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.

Practice Information

  • Specialty Medical
  • Location Athens, TX
  • Active Since 08/09/2006
  • Last Updated 04/16/2015
  • Taxonomy Code 363AM0700X
  • Entity Type Individual
  • NPI Number 1821008970

Products in Payments

  • GEMTESA (Drug) $325.73
  • XYOSTED (Drug) $184.75
  • ORGOVYX (Drug) $179.97
  • XTANDI (Drug) $162.01
  • Myrbetriq (Drug) $109.67
  • Xtandi (Drug) $97.88
  • LUPRON DEPOT (Drug) $63.67
  • Nubeqa (Drug) $60.07
  • Axonics (Device) $58.74
  • Titan (Device) $43.71
  • AQUABEAM SYSTEM (Device) $40.51
  • PROVENGE (Drug) $33.64
  • UroLift System (Device) $25.98
  • REZUM (Device) $20.17
  • ELIGARD (Drug) $19.62
  • OMNIGRAFT (Device) $17.89
  • Prolia (Biological) $17.80
  • ADVANTAGE (Device) $11.04

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Medical Doctors in Athens